Health knowledge made personal
WellPage for 5-centimeter Squamous Tumor In Brain From Lung Cancer
+ Bookmark › Share
Search posts:

5-centimeter Squamous Tumor In Brain From Lung Cancer - Articles

Lung cancer metastasis: new drugs in the market? by Dr. Nagaraj Posted Thu 05 Nov 2009 5:12am Lung cancer: The lungs are a pair of cone-shaped breathing organs in the chest. The lungs bring oxygen into the body as you breathe in. They release carbon dioxide, a waste product of the body’s cells, as you breathe out. Each lung has sections called lobes. The left lung has two lobes. The right lung is slightly larger and has three lobes. Tw ... Read on »
Avastin Largely Safe for Patients With Type of Advanced Lung Cancer by HealthFinder Posted Tue 20 Jul 2010 10:00am healthnewslink Post-marketing research shows some serious side effects, but most are controllable. By Steven Reinberg HealthDay Reporter ... Read on »
Avastin Largely Safe for Patients with Type of Advanced Lung Cancer by Medline Plus Posted Tue 20 Jul 2010 11:00am Post-marketing research shows some serious side effects, but most are controllable Tuesday, July 20, 2010 TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung ... Read on »
Rosetta Genomics Interview – microRNA for Diagnosing Lung Cancer Tumors by Medical Quack Patient ExpertHealth Maven Posted Sun 11 Jan 2009 4:20pm Tests to detect cancer of the unknown primary Rosetta Genomics – Today I had the opportunity to speak with and interview Ronen Tamir, Chief Commercialization Officer, at Rosetta to find out how microRNA is helping diagnose and treat cancer.   If you have been keeping up with the news of late, Rosetta in the last couple of weeks has had 3 pr ... Read on »
Experimental Drug Makes Lung Cancer Tumor Shrink In 90% Of Patients by Karen Bastille Health Maven Posted Sun 06 Jun 2010 8:48am Medical News Today An extremely promising experimental drug, called crizotinib for lung cancer patients with a specific gene has shrunk tumors in 90% of patients in a clinical study within two months, researchers from Pfizer. Inc. said. With expectations of just a 10% response rate to this new medication - which would ha ... Read on »
ALK Inhibition in Non-Small Cell Lung Cancer and Inflammatory Myofibroblastic Tumor by Mark Pool, MD Posted Thu 28 Oct 2010 9:51pm Great stuff in this week's NEJM! Today's (October 28, 2010) New England Journal of Medicine has no less than three articles reporting the use of small molecule ALK tyrosine kinase inhibitor crizotinib (PF-02341066, Pfizer) in non-small-cell lung cancers harboring the oncogenic fusion gene EML4-ALK and in a patient with ALK-rearrangemen ... Read on »
Marijuana Cuts Lung Cancer Tumor Growth In Half, Study Shows by Matthew Z. Patient Expert Posted Tue 10 Feb 2009 10:11am The active ingredient in marijuana cuts tumor growth in common lung cancer in half and significantly reduces the ability of the cancer to spread, say researchers at Harvard University. Researchers do not know why THC inhibits tumor growth, they say the substance could be activating molecules that arrest the cell cycle. read more | digg story Read on »
Many Lung Cancer Tumors May Prove Harmless, Study Finds by Medline Plus Posted Mon 09 Dec 2013 5:00pm Research suggests CT scan screening might lead to needless worry, treatment in these cases Source: HealthDay Related MedlinePlus Pages: CT Scans , Lung Cancer Read on »
Small-cell vs. squamous-cell lung cancer by pathologystudent Posted Thu 01 Dec 2011 1:25pm     I received an email yesterday that had questions about a post from a couple years ago – and rather than bury the answers way back in 2009, I thought I’d make a new post. The questions provide a good foundation for discussing some of the morphologic differences between squamous cell carcinoma and small cell carcinoma, two com ... Read on »
Novel Lung Cancer Vaccine Shows Promise In Fighting Early-Stage Lung Cancer by COPDsurvivor Patient Expert Posted Thu 23 Apr 2009 5:25pm An experimental vaccine that triggers the patient’s immune system to identify and attack specific tumor cells is showing new promise for the treatment of early lung cancer. Thoracic surgeons at Rush University Medical Center are researching the vaccine called MAGE-A3 Antigen-Specific Cancer Immunotherapeutic, which is designed to kill cancer ... Read on »